GeneTex
  • Country / Location Selection

United States (US)

FOXC1 (internal) blocking peptide

Cat. No. GTX89469-PEP

Species

Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX89469.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-DAVKDKEEKDRLH

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Forkhead Box C1 , Ara , Asgd3 , Fkhl7 , Freac-3 , Freac3 , Igda , Ihg1 , Irid1 , Rieg3 , Foxc1

Background

This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it has been shown to play a role in the regulation of embryonic and ocular development. Mutations in this gene cause various glaucoma phenotypes including primary congenital glaucoma, autosomal dominant iridogoniodysgenesis anomaly, and Axenfeld-Rieger anomaly. [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for FOXC1 (internal) blocking peptide (GTX89469-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for FOXC1 (internal) blocking peptide (GTX89469-PEP). Be the first to share your experience with this product.
Package List Price ($)
$ 239